THERAVANCE INC - CORPORATE OBLIG

CUSIP: 88338TAB0

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Debt / CORPORATE OBLIG
Market price (% of par)
145.38%
Total 13F principal
$261,511,000
Principal change
+$792,000
Total reported market value
$380,473,000
Number of holders
27
Value change
+$1,124,879
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 88338TAB0?
CUSIP 88338TAB0 identifies 88338TAB0 - THERAVANCE INC - CORPORATE OBLIG in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - CORPORATE OBLIG as of Q4 2013

As of 31 Dec 2013, THERAVANCE INC - CORPORATE OBLIG was held by 27 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $261,511,000 in principal (par value) of the bond. The largest 10 bondholders included FMR LLC, ADVENT CAPITAL MANAGEMENT /DE/, WOLVERINE ASSET MANAGEMENT LLC, Citadel Advisors LLC, CAMDEN ASSET MANAGEMENT L P /CA, Pioneer Investment Management Inc, ANGELO GORDON & CO., L.P., PALISADE CAPITAL MANAGEMENT LLC/NJ, SYMPHONY ASSET MANAGEMENT LLC, and HIGHBRIDGE CAPITAL MANAGEMENT LLC. This page lists 27 institutional bondholders reporting positions for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.